R-5280

· Rise Therapeutics LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R-5280, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: R-5280 in Newly Diagnosed Patients With Type 1 Diabetes [Phase 1]